MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11255-025-04485-3

Медицинская библиотека · International urology and nephrology · 2025

Treatment outcomes and comparative survival analysis of intraductal carcinoma of the prostate.

Stamey Taylor, Armel Kristen, Ju Andrew W, Chen Shoujun, Navaid Musharraf, Bhatt Arjun, Larkins Michael C

СтатьяСравнительное исследованиеПеревод в очереди

Аннотация

PURPOSE: Intraductal carcinoma of the prostate is a rare subset of prostate cancer, for which no consensus treatment guidelines exist. We seek to investigate treatment and survival outcomes for IDC-P in the context of current NCCN guidelines.

METHODS

The Surveillance, Epidemiology, and End Results (SEER) database was queried to identify patients with intraductal carcinoma of the prostate diagnosed between 2000 and 2020. Cox regression analysis and log-rank comparisons of both overall and cause-specific survival over 5- and 10-year timeframes were conducted.

RESULTS

945 patients were identified. Cox regression analysis demonstrated treatment with unimodal surgery (hazard ratio (HR) = 3.70, p = 0.005) was associated with decreased 10-year cause-specific survival, while unimodal treatment with radiotherapy was associated with decreased 5- and 10-year overall survival (HR = 2.14, p = 0.025; HR = 2.16, p = 0.005, respectively). Univariate survival subanalysis of treatment regimens demonstrated decreased 5-year cause-specific (p = 0.004) and overall (p = 0.019) survival among patients that received only radiotherapy as treatment. Radical prostatectomy alone was non-inferior to radical prostatectomy with adjuvant radiotherapy in the context of 10-year overall survival (90% vs 80%; p = 0.58).

CONCLUSION

Differences in both 5- and 10-year overall survival and cause-specific survival were present among patients diagnosed with IDC-P. Treatment with unimodal radiotherapy among patients with IDC-P was associated with decreased survival compared to treatment with radical prostatectomy ± adjuvant radiotherapy, while radical prostatectomy alone was non-inferior to radical prostatectomy with adjuvant radiotherapy. Further research into the risk stratification and optimal treatment of these patients is warranted.

Для цитирования: Stamey Taylor, Armel Kristen, Ju Andrew W, Chen Shoujun, Navaid Musharraf, Bhatt Arjun, Larkins Michael C. Treatment outcomes and comparative survival analysis of intraductal carcinoma of the prostate.. International urology and nephrology. 2025. DOI: 10.1007/s11255-025-04485-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.